Rankings
▼
Calendar
LUNG Q2 2023 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena
LUNG
Pulmonx Corporation
$75M
Q2 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$17M
+23.3% YoY
Gross Profit
$13M
74.1% margin
Operating Income
-$16M
-95.6% margin
Net Income
-$16M
-94.2% margin
EPS (Diluted)
$-0.43
QoQ Revenue Growth
+18.3%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$193M
Total Liabilities
$59M
Stockholders' Equity
$134M
Cash & Equivalents
$102M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$17M
$14M
+23.3%
Gross Profit
$13M
$10M
+22.2%
Operating Income
-$16M
-$14M
-14.1%
Net Income
-$16M
-$15M
-10.6%
Geographic Segments
UNITED STATES
$11M
64%
EMEA
$5M
31%
Asia Pacific
$792,000
5%
Other International Geographical Areas
$68,000
0%
← FY 2023
All Quarters
Q3 2023 →